Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, and EXACT Therapeutics (Euronext Growth: EXTX), a clinical-stage precision medicine company, are pleased ...
Pancreatic cancer five-year relative survival: 12.8% Pancreatic cancer has a 12.8% five-year survival rate. It can be effectively treated if detected early, but when diagnosed at more advanced ...
Background and Aim: We report our single-centre experience with endoscopic ultrasound guided fine needle aspiration (EUS-FNA) of solid pancreatic lesions with regard to clinical utility ...
Background: To estimate the global burden of pancreatic cancer in 2019 and 2021 including incidence, mortality, and disability-adjusted-life-years (DALYs). Methods: Data on pancreatic cancer incidence ...